Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Rectal Neoplasms 49Breast Neoplasms 48Stomach Neoplasms 37Esophageal Neoplasms 36Colorectal Neoplasms 33Lung Neoplasms 30Squamous Cell Carcinoma of Head and Neck 28Pancreatic Neoplasms 25Brain Neoplasms 25Glioblastoma 23Neoplasms 22Sarcoma 21Neoplasm Metastasis 20Carcinoma, Hepatocellular 18Head and Neck Neoplasms 17Glioma 16Esophageal Squamous Cell Carcinoma 16Colonic Neoplasms 13Recurrence 11Ovarian Neoplasms 10Oropharyngeal Neoplasms 10Melanoma 10Astrocytoma 10Adenocarcinoma Of Esophagus 10Thyroid Neoplasms 9Hypopharyngeal Neoplasms 9Prostatic Neoplasms 8Laryngeal Neoplasms 8Central Nervous System Neoplasms 8

Interventions

Cyclophosphamide 10fludarabine 5Radiotherapy 5Doxorubicin 5Gemcitabine 3sargramostim 2fludarabine phosphate 2aldesleukin 2Sunitinib 2Radiation Dose Hypofractionation 2Nivolumab 2Leukapheresis 2Ifosfamide 2Docetaxel 2Decitabine 2Dacarbazine 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2trofosfamide 1tremelimumab 1temsirolimus 1sotigalimab 1ribociclib 1poly ICLC 1pembrolizumab 1pegfilgrastim 1pazopanib 1pasireotide 1olaparib 1lutetium Lu 177 dotatate 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Synovial × Surgical Procedures, Operative × Clear all
NCT00356031 2017-05-19

Bevacizumab and Radiation Therapy for Sarcomas

Massachusetts General Hospital

Phase 2 Completed
20 enrolled 16 charts
Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Histiocytoma, Benign Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡